AGA
SGNT

Altrinsic Global Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Altrinsic Global Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-371,100
Closed -$5.56M – 84
2016
Q2 		$5.56M Buy
371,100
+40,000
+12% +$514K 0.16% 54
2016
Q1 		$4.03M Hold
331,100
– – 0.11% 66
2015
Q4 		$5.27M Hold
331,100
– – 0.14% 60
2015
Q3 		$5.08M Buy
331,100
+50,000
+18% +$1.08M 0.12% 60
2015
Q2 		$6.83M Buy
281,100
+44,500
+19% +$1.07M 0.14% 55
2015
Q1 		$5.5M Buy
+236,600
New +$6.26M 0.12% 59

Altrinsic Global Advisors's SGNT Position: Q3 2016 in Review

Altrinsic Global Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 371,100 shares — an estimated $5.56M sold.

Altrinsic Global Advisors first reported a position in SGNT in Q1 2015 and held it in 6 quarters. The position peaked at $6.83M in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Altrinsic Global Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Altrinsic Global Advisors sold 371,100 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $5.56M.
  • Altrinsic Global Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 6 quarters.
  • Altrinsic Global Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $6.83M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Altrinsic Global Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.